Cover Image

Real‐world evidence for comprehensive evaluation of guselkumab in the treatment of psoriasis

Fuente: Wiley Open Access

Saved in:

Bibliographic Details
Main Author:	Diamant Thaçi
Format:	Artículo Open Access
Published:	Wiley 2025
Subjects:	Journal of the European Academy of Dermatology and Venereology
Online Access:	Acceder al recurso
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

The real‐world, long‐term risk of infections associated with dupilumab in atopic dermatitis: A global cohort study
by: Khalaf Kridin, et al.
Published: (2025)

Exposure–response relationship of guselkumab and the potential of serum proteomics in identifying predictive biomarker candidates in psoriasis
by: R. Soenen, et al.
Published: (2024)

Management of moderate to severe psoriasis with brodalumab—Real‐world evidence from the LIBERO study
by: R. von Kiedrowski, et al.
Published: (2024)

Eczematous reaction to guselkumab successfully treated with upadacitinib
by: Hector Moreno‐Davila, et al.
Published: (2025)

Reply to ‘Delayed absorption and systemic variability of topical delgocitinib in Chronic Hand Eczema’
by: Diamant Thaçi, et al.
Published: (2025)

Systemic exposure and bioavailability of delgocitinib cream in adults with moderate to severe Chronic Hand Eczema
by: Diamant Thaçi, et al.
Published: (2025)

Optical coherence tomography‐based imaging biomarkers for disease activity monitoring in plaque psoriasis
by: L. Ha‐Wissel, et al.
Published: (2024)

Paediatric psoriasis and biologics: An evidence gap in plain sight
by: Stephan Traidl, et al.
Published: (2026)

Deucravacitinib in plaque psoriasis: Four‐year safety and efficacy results from the Phase 3 POETYK PSO‐1, PSO‐2 and long‐term extension trials
by: April W. Armstrong, et al.
Published: (2025)

Real‐world data on the effectiveness of brodalumab in patients with moderate‐to severe plaque psoriasis in the Greek clinical setting (the BrIDGE study)
by: Dimitrios Rigopoulos, et al.
Published: (2024)

Long‐term effects of sirolimus treatment for slow‐flow vascular malformations: Real‐world evidence from the French observational multicentre SIROLO study
by: Cécilia Maillet, et al.
Published: (2024)

Belgian recommendations for managing psoriasis in a changing treatment landscape
by: R. Speeckaert, et al.
Published: (2024)

Real‐world effectiveness, drug survival and safety of risankizumab over a period of 2 years in 158 patients with moderate‐to‐severe plaque psoriasis
by: Natalia Rompoti, et al.
Published: (2024)

Clarifying methodological foundations in network meta‐analyses of paediatric psoriasis treatments
by: Jian Huang
Published: (2025)

Efficacy and safety of bimekizumab in the treatment of genital psoriasis: A case series
by: L. Bettolini, et al.
Published: (2024)

Dupilumab shows no elevated risk for maternal adverse pregnancy outcomes: A propensity‐matched cohort study
by: Sophie L. Preuß, et al.
Published: (2025)

Systemic treatment of immune checkpoint inhibitor‐induced psoriasis: Inference‐based guidance
by: Kim A. Papp, et al.
Published: (2025)

Drug survival of systemic treatments for severe paediatric psoriasis: An international retrospective study
by: Yunyun Miao, et al.
Published: (2025)

French guidelines on systemic treatments for moderate‐to‐severe psoriasis in adults: Update 2025
by: Marie Masson Regnault, et al.
Published: (2025)

Biologics for treatment of paediatric plaque psoriasis: A systematic review and network meta‐analysis
by: Abdullah Ali Aljalfan, et al.
Published: (2025)

Switching within the class of IL‐23 inhibitors for the treatment of psoriasis: A systematic review
by: Ioannis‐Alexios Koumprentziotis, et al.
Published: (2025)

Ocular complications in patients with psoriasis: Is dry eye associated with psoriasis?
by: Marina Talamonti, et al.
Published: (2024)

Risk of adverse events of psoriasis treatment with biologic agents and new small molecules—BIOBADADERM Registry
by: María Olivares‐Guerrero, et al.
Published: (2025)

Effectiveness and safety of methotrexate in the treatment of mycosis fungoides: Real‐world data from a multicentre study
by: Vasiliki Nikolaou, et al.
Published: (2024)

Dysregulation of epigenetic, biological and mitotic age in the context of biologic drug treatment and phototherapy in plaque psoriasis patients
by: Richie Jeremian, et al.
Published: (2024)

Reassuring evidence on infection risk with dupilumab in atopic dermatitis: Lessons from real‐world evidence
by: Lian F. van der Gang, et al.
Published: (2025)

Napkin psoriasis and the risk of later psoriasis development: A single‐centre retrospective study
by: Iria Neri, et al.
Published: (2024)

The effect of age on the severity of psoriasis
by: Shir Azrielant, et al.
Published: (2024)

Anti‐IL‐23 therapy for the treatment of moderate‐to‐severe inverse psoriasis: A 52‐week multicenter study
by: Joan Ceravalls, et al.
Published: (2024)

Treatment of psoriasis with biologic and non‐biologic targeted therapies in patients with latent tuberculosis infection or at risk for tuberculosis disease progression: Recommendations from a SPIN‐FRT expert consensus
by: T. Torres, et al.
Published: (2024)

The lifestyle of psoriasis patients and their motivation to change
by: M. Al‐Gawahiri, et al.
Published: (2024)

Towards a more comprehensive evaluation: Addressing limitations in the study of dupilumab and pregnancy outcomes
by: Lei Zhang, et al.
Published: (2025)

Sodium intake: An emerging dietary target in psoriasis
by: Stephen Chu‐Sung Hu, et al.
Published: (2025)

Defining ambiguity in molecular differentiation of psoriasis and eczema
by: Jie Pang
Published: (2026)

Comparative effects of biologics on anxiety and depression symptoms in psoriasis
by: Yuxiong Jiang, et al.
Published: (2025)

Closing the gap between possibilities and reality in psoriasis management
by: Rolland Gyulai
Published: (2025)

Shedding pounds, easing plaques: Weight management in psoriasis
by: Dimitra Koumaki, et al.
Published: (2026)

Reframing molecular superiority in the differential diagnosis of eczema and psoriasis
by: Man Sun, et al.
Published: (2026)

Methodological considerations for smoking cessation, weight change, and psoriasis
by: Yinuo Chen, et al.
Published: (2026)

Nail clipping may not be sufficient to corroborate the diagnosis of psoriasis
by: L. Bertanha, et al.
Published: (2024)